ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 665713 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 665713; 2) Community: the network communities that were significantly associated with the response to NSC 665713; 3) Molecule: the relationships between components within communities and NSC 665713; 4) MDR: the compounds that were significantly associated with the NSC 665713.

NSC Compound Enrichment Correlation
NSC 740 Methotrexate 0.0282295482823984 0.0058340601
NSC 743528 Null 0.0282295482823984 0.23462513
NSC 758423 Amsacrine (USAN) 0.0282295482823984 0.065284913
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0282295482823984 0.0073230666
NSC 349644 CYANOCYCLINE A (CHUGAI) 0.0282295482823988 0.16911319
NSC 366241 Ditercalinium dimethanesulfonate dimethanesulfonate 0.0282295482823988 0.26953471
NSC 382034 2,4-Pyrimidinediamine, 6-ethyl-5-[4-(methylamino)- 3-nitrophenyl]- 0.0282295482823988 0.069251513
NSC 605583 3,5-Dioxa-4-phosphaunacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt, 4-oxide 0.0282295482823988 0.18797758
NSC 631477 p-Chloranilinum[bis(p-chloraniline)dioxalatoruthenate(III)] 0.0282295482823988 0.086528605
NSC 637126 Null 0.0282295482823988 0.11320215
Total:50  Current:30    [First] [Prev] [Next] [Last]